Effects of 17β-estradiol (E2) on mature female squirrelfish
. | Day 5 . | . | Day 6 . | . | Day 10 . | . | |||
---|---|---|---|---|---|---|---|---|---|
. | Control . | E2 treated . | Control . | E2 treated . | Control . | E2 treated . | |||
Liver zinc | 2.32±2.84 | 3.36±0.69 | 6.12±1.06 | 3.61±1.01 | 7.13±1.83 | 14.2±6.35 | |||
VTG | 0.43±0.27 | 33.0±2.82* | 0.55±0.27 | 24.9±8.66* | 0.13±0.06 | 12.1±2.12* | |||
E2 | 1.17±0.08 | 11.4±5.10* | 2.53±0.95 | 18.2±8.95* | 1.61±0.21 | 0.13±0.04* | |||
T | 2.92±0.28 | 0.10±0.03* | 3.06±0.13 | 0.09±0.05* | 2.88±0.29 | 0.25±0.14* | |||
P | 31.2±8.51 | 3.95±0.52* | 32.0±3.31 | 3.67±0.83* | 36.1±3.65 | 3.47±0.77* | |||
MT mRNA | 1.03±0.18 | 0.82±0.10 | 1.01±0.13 | 0.72±0.11 | 0.98±0.24 | 0.93±0.14 | |||
C MT | 1.29±0.60 | 0.48±0.05* | 0.63±0.20 | 1.01±0.08 | 0.64±0.09 | 0.81±0.04 |
. | Day 5 . | . | Day 6 . | . | Day 10 . | . | |||
---|---|---|---|---|---|---|---|---|---|
. | Control . | E2 treated . | Control . | E2 treated . | Control . | E2 treated . | |||
Liver zinc | 2.32±2.84 | 3.36±0.69 | 6.12±1.06 | 3.61±1.01 | 7.13±1.83 | 14.2±6.35 | |||
VTG | 0.43±0.27 | 33.0±2.82* | 0.55±0.27 | 24.9±8.66* | 0.13±0.06 | 12.1±2.12* | |||
E2 | 1.17±0.08 | 11.4±5.10* | 2.53±0.95 | 18.2±8.95* | 1.61±0.21 | 0.13±0.04* | |||
T | 2.92±0.28 | 0.10±0.03* | 3.06±0.13 | 0.09±0.05* | 2.88±0.29 | 0.25±0.14* | |||
P | 31.2±8.51 | 3.95±0.52* | 32.0±3.31 | 3.67±0.83* | 36.1±3.65 | 3.47±0.77* | |||
MT mRNA | 1.03±0.18 | 0.82±0.10 | 1.01±0.13 | 0.72±0.11 | 0.98±0.24 | 0.93±0.14 | |||
C MT | 1.29±0.60 | 0.48±0.05* | 0.63±0.20 | 1.01±0.08 | 0.64±0.09 | 0.81±0.04 |
Effects of 17β-estradiol (E2) on mature female squirrelfish in terms of liver zinc, plasma vitellogenin (VTG), testosterone (T),17β-estradiol (E2) and progesterone (P) levels; hepatic metallothionein mRNA levels (MT mRNA); and MT protein levels in cytosolic (C)liver fractions.Other details as in Table 2.